Analysis · Healthcare & Life Sciences

Biorad Medisys tops funded healthtech startups list in Pune for 2026

By Startup Enthusiast · 20 August 2026

What they do

Biorad Medisys leads the top 20 funded healthtech startups in Pune with $55.3 million total funding

The company was founded in 2007 and currently employs 812 people across its operations

Fittr ranks second with $17 million funding while Brinton Pharmaceuticals holds the third spot

Biorad Medisys is ranked as the top funded healthtech startup in Pune for the year 2026.
The company has raised a total of $55.3 million in funding over its history.
It reached its last funding stage classified as Private Equity according to available records.
The organization currently employs 812 people as part of its operational workforce.
Fittr secures the second position on the list with $17.0 million in total funding.
Founded in 2016, Fittr maintains a team of 675 employees at this time.
Brinton Pharmaceuticals takes the third spot having raised $13.4 million in total capital.
This pharmaceutical firm was established in 2014 and employs 697 individuals.

The list highlights the concentration of health technology investment within the Pune ecosystem.
Funding totals vary significantly from millions down to thousands across the top twenty companies.
Employee counts range widely indicating different stages of growth among these startups.

Biorad Medisys operates as a health technology entity based in the Pune region.
The company focuses on medical solutions within the broader healthtech sector landscape.
Its business model supports healthcare delivery through technological innovation and services.
The firm manages a substantial workforce of over eight hundred employees globally.
Investors have provided significant capital to support its expansion and development efforts.
The company continues to operate under private equity ownership structures.
It remains one of the most capitalized healthtech firms in its local market.
The organization leverages its funding to maintain competitive advantages in the industry.
Its long-standing presence since 2007 suggests sustained operational viability and growth.